
ACCESSING THIS CHALLENGE
If you have not registered at Innoget yet and want to access our Challenges, do it now. It's free

If you are already registered at Innoget, please enter your data:
Message to Open Companies


| Challenge ID >> | C-00132 |
| Industrial sector >> | Biotechnology |
| Country >> | Spain ![]() |
| Budget >> | Not available |
| Deadline >> | 2010-09-30 |
| Proposals received >> | 1 |
| Tags >> | Dopamine, Neurodegeneration, Neurodegenerative, Stem Cells, Cell, self-renewal, renewal, expasion, Parkinson's, growth factor |
Company profile
A european biotech company is developing a new treatment of neurodegenerative diseases (e.g. parkinson⠹s) based upon the administration of stem cells.
Challenge: Stem cell expansion methods and compositions.
A european biotech company is developing a new treatment of neurodegenerative diseases (e.g. parkinson⠹s) based upon the administration of stem cells.


